e8vk
Table of Contents

 
 
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 16, 2007
NUVASIVE, INC.
(Exact name of registrant as specified in its charter)
         
Delaware   000-50744   33-0768598
(State or Other Jurisdiction of   (Commission File   (I.R.S. Employer Idenitifcation
Incorporation)   Number)   Number)
4545 Towne Centre Court, San Diego, California 92121
(Address of principal executive offices, with zip code)
(858) 909-1800
(Registrant’s telephone number, including area code)
n/a
(Former name or former address, if changed since last report)
     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


TABLE OF CONTENTS

Item 1.01 Entry Into A Material Definitive Agreement
SIGNATURES


Table of Contents

Item 1.01 Entry Into A Material Definitive Agreement
On January 16, 2007, the Compensation Committee of the Board of Directors of NuVasive, Inc. (the “Company”), set annual base salaries for the Company’s executive officers for calendar year 2007, effective January 1, 2007. The base salaries for the Company’s named executive officers (as defined in Item 402(a)(3) of Regulation S-K) were established as follows:
             
Name   Position   2007 Salary
Alexis V. Lukianov
  Chairman and Chief Executive Officer   $ 450,000  
Keith C. Valentine
  President and Chief Operating Officer   $ 325,000  
Kevin C. O’Boyle
  Executive Vice President and Chief Financial Officer   $ 285,000  
Patrick Miles
  Executive Vice President, Marketing and Product Development   $ 275,000  
Jeffrey Rydin
  Senior Vice President, U.S. Sales   $ 260,000  

 


Table of Contents

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  NUVASIVE, INC.
 
 
Date: January 22, 2007  By:   /s/ Alexis V. Lukianov    
    Alexis V. Lukianov   
    Chairman and Chief Executive Officer